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Abstract
Voltage-dependent anion channels (VDACs, also known as mitochondrial porins) are small pore-forming proteins of the
mitochondrial outer membrane found in all eukaryotes. Mammals harbor three distinct VDAC isoforms, with each protein
sharing 65^70% sequence identity. Deletion of the yeast VDAC1 gene leads to conditional lethality that can be partially or
completely complemented by the mammalian VDAC genes. In vitro, VDACs conduct a variety of small metabolites and in
vivo they serve as a binding site for several cytosolic kinases involved in intermediary metabolism, yet the specific physiologic
role of each isoform is unknown. Here we show that mouse embryonic stem cells lacking each isoform are viable but exhibit a
30% reduction in oxygen consumption. VDAC1 and VDAC2 deficient cells exhibit reduced cytochrome c oxidase activity,
whereas VDAC3 deficient cells have normal activity. These results indicate that VDACs are not essential for cell viability and
we speculate that reduced respiration in part reflects decreased outer membrane permeability for small metabolites necessary
for oxidative phosphorylation. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
Voltage-dependent anion channels (VDACs) are
the major pathway for metabolites across the mito-
chondrial outer membrane and are found in all eu-
karyotes. Despite limited amino acid homology
VDACs share characteristic electrophysiologic fea-
tures across a wide phylogenetic spectrum (reviewed
in [1]). In Saccharomyces cerevisiae two structurally
related VDACs (YVDAC1 and YVDAC2) have been
identi¢ed [2,3], although YVDAC2, while localized
to the mitochondrial outer membrane, apparently
lacks channel activity [3]. Yeasts lacking YVDAC1
fail to grow on a non-fermentable carbon source at
37‡C, but the biochemical basis for this temperature
sensitive phenotype is unknown [4]. It has been dem-
onstrated in yeast that YVDAC1 confers permeabil-
ity to the mitochondrial outer membrane [5].
In the mouse three distinct isoforms have been
described [2,6], with the gene structures indicative
of a gene family that arose by duplication and diver-
gence [7]. While the biophysical features of the
mouse VDACs have been partially characterized
[8], the physiological roles of various VDAC iso-
forms remain to be elucidated. It has been speculated
that VDACs play a role in the regulation of mito-
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chondrial and cellular energy metabolism via the reg-
ulation of metabolite £ux across the outer membrane
and by the binding of several cytosolic (‘ambiqui-
tous’) kinases [9,10]. The interaction with various
kinases occurs in a developmental and tissue speci¢c
manner [11]. Furthermore, prior studies indicate that
mitochondrially bound hexokinase selectively uses
intramitochondrial ATP [12], an observation in con-
cert with the demonstration of direct £ow of ATP
through isolated VDAC [13].
Evidence that the mouse VDAC isoforms, when
expressed in yeast, di¡er in their permeability char-
acteristics [8] lends support to the possibility that
VDACs have distinct physiologic functions, as does
the di¡ering ability of each isoform to complement
YVDAC1 de¢ciency [7]. To determine whether
VDAC de¢cient mammalian cells are viable, embry-
onic stem (ES) cell lines singularly lacking each
VDAC isoform were generated by homologous re-
combination. Cellular respiration was measured in
intact cells in order to search for functional conse-
quences of VDAC de¢ciency.
2. Materials and methods
2.1. Construction of VDAC targeting plasmids
The VDAC1 targeting vector was designed to de-
lete a 3.7 kb HindIII fragment containing exons 2^5.
There is no other in-frame start codon in the remain-
ing 3P coding region of the gene. A 5P 7.2 kb EcoRI/
HindIII fragment and a 3P 3.9 kb HindIII/NotI frag-
ment were subcloned from digested 129SvJ genomic
V DNA into a pBluescript KS vector. The vector was
linearized at a HindIII site within the polylinker, and
a 1.4 kb neomycin resistance gene cassette (pol2-
shortneobpa) digested with HindIII [14] was ligated
into the site. The HSV-tk gene was inserted into the
NotI site [15].
The VDAC2 gene was isolated from a Stratagene
isogenic 129SvEv strain genomic V DNA library. The
construct was generated by subcloning both a 4.8 kb
SpeI/BamHI fragment and a 5.7 kb EcoRI fragment
into the pBluescript KS vector. This is designed to
delete the promoter and ¢rst two exons, including the
predicted start codon [7]. The vector was linearized
with SmaI and the pol2shortneobpa cassette was
blunt-ended with Klenow DNA polymerase and li-
gated. The HSV-tk gene was subcloned into the NotI
site.
The VDAC3 targeting vector deletes a 4.1 kb
BglII/NcoI fragment containing the last four of the
nine exons of the VDAC3 gene [7]. A 5P 3.8 kb BglII
fragment and a 3P 3.9 kb NcoI/NotI fragment were
subcloned into the pBluescript KS vector. The vector
was then linearized with EcoRV, and the pol2short-
neobpa cassette was blunt-end ligated into the site.
Finally, the HSV-tk gene was inserted into the NotI
site.
2.2. Cell culture and transfection
Each VDAC construct was linearized with PvuI in
the vector plasmid backbone. Early passage, hprt3
AB2.1 [16] and AB2.2 ES cells (provided by Dr. Alan
Bradley, Baylor College of Medicine) [17] were elec-
troporated and subjected to G418 and FIAU selec-
tion as described. Drug resistant colonies were
screened by the ‘mini-Southern’ procedure [18]. For
VDAC1, ES cell genomic DNA was digested with
BamHI. A VDAC1 0.8 kb EcoRI/SacI genomic frag-
ment, when used as a radiolabeled probe, detects a
15.7 kb mutant band as well as an 18 kb wild-type
band. For the VDAC2 construct, by using a 2.1 kb
SpeI/EcoRI genomic fragment at the 5P end of the
VDAC2 gene as a probe, an XbaI digest of the ES
cell genomic DNA identi¢es a 7.3 kb mutant band as
well as a 12.2 kb wild-type band. Genomic DNA
from ES cell colonies electroporated with the
VDAC3 construct was digested with EcoRI and
screened using a 0.7 kb NotI/SpeI genomic fragment.
The probe detects a 7.6 kb fragment in an ES cell
that has undergone homologous recombination with
the VDAC3 replacement vector, as well as a 11.7 kb
wild-type fragment.
2.3. Isolation of homozygous VDAC de¢cient ES cells
To generate homozygous de¢cient cells, hetero-
zygous ES cells targeted with each of the VDAC
constructs were grown under high G418 selection
as outlined by Mortesen et al. [19]. The cells were
plated at 104 cells per 10 cm dish with mitomycin C
inactivated feeder cells. After 24 h, 1 mg/ml, 2 mg/ml,
or 4 mg/ml of G418 was added to the culture media.
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Selection proceeded for 14 days, and surviving indi-
vidual colonies were picked and screened by South-
ern blot analysis for loss of the wild-type allele. In
addition to increased G418 selection, targeting of the
remaining allele by homologous recombination was
carried out for VDAC1 and VDAC2. Targeting vec-
tors with identical genomic arms were generated for
each of the three VDAC isoforms with a puromycin
expression cassette substituting for the neomycin cas-
sette used originally. To conserve available selectable
markers for subsequent experiments, a puromycin
cassette £anked by loxP sites was generated [20].
Heterozygous VDAC1 and VDAC2 ES cell clones
were electroporated, puromycin selection was ap-
plied, and colonies were screened for homologous
recombination events as previously described.
To try to disrupt additional VDAC loci, VDAC1
and VDAC2 homozygous null ES cell clones targeted
with both neomycin and puromycin cassettes were
electroporated with a Cre expression plasmid (a gift
from Dr. Steve O’Gorman, The Salk Institute). The
cells were plated at a low density and screened for
the loss of the puromycin cassette by Southern blot
analysis (data not shown). Homozygous ES cell
clones that had undergone the Cre mediated excision
were then electroporated with a puromycin targeting
construct of another VDAC isoform.
2.4. Northern blot analysis of VDAC de¢cient
ES cells
Total RNA from each null cell line was extracted
using guanidinium isothiocyanate [21], fractionated
on a formaldehyde/agarose gel (1%), transferred to
a GeneScreen Plus membrane (Dupont), and
screened for the loss of VDAC isoform expression.
Loading and RNA intactness was assessed by ethi-
dium bromide staining of 18S and 28S RNA and
with a second radiolabeled probe for GAPDH. To
avoid problems with cross-hybridization the mem-
branes were probed with the 5P or 3P untranslated
region of each mouse VDAC cDNA. The hybridiza-
tions were carried out overnight at 65‡C. in Blotto
(1.5USSPE/1% SDS/0.5% non-fat dried milk).
2.5. Metabolic studies of VDAC de¢cient ES cells
Wild-type and VDAC de¢cient ES cells were cul-
tured in high glucose (4.5%) DMEM supplemented
with 2 mM glutamine, 15% fetal calf serum, and
recombinant leukemia inhibitory factor (LIF; 1000
U/ml; Gibco BRL) over 3^4 days until approxi-
mately 80^90% con£uence. Cells were fed with fresh
medium 2 h before harvesting, then trypsinized,
washed in PBS, suspended in ES cell medium and
counted. Oxygen consumption was determined with
a Clark-type oxygen electrode (Yellow Spring Instru-
ments) connected to a chart recorder, as described by
Estabrook [22]. Typically, 5U106 cells were incu-
bated in 2.6 ml of ES cell medium at 30‡C. Oxygen
consumption was calculated for each cell line under
baseline conditions, in the presence of the ATP syn-
thase inhibitor oligomycin (10 WM; Sigma), or with
20 WM carbonyl cyanide m-chlorophenylhydrazone
(CCCP; Sigma), an uncoupler of oxidative phos-
phorylation. To calculate respiration rates, the solu-
bility of oxygen was taken as 468 Wmol atomic oxy-
gen/ml [22]. Protein content was determined using
the BCA reagent kit (Pierce, Inc.). A diagnostic kit
for lactate (Sigma 735-10) was used to determine
lactate concentrations in cellular extracts. Citrate
synthase and cytochrome c oxidase activities were
determined as described by Williams et al. [23].
Hexokinase activity was determined according to
Wilson [24].
2.6. Western analysis using a VDAC1 speci¢c
antibody
Cells were cultured as above, trypsinized, pelleted
and resuspended twice in cold NKM (130 mM NaCl,
5 mM KCl, 7.5 mM MgCl2). Following this step, all
operations were performed at 4‡C [25]. Cells were
then pelleted again, resuspended in 5 ml RSB (10
mM Tris-HCl, 10 mM KCl, 0.15 mM MgCl2, pH
6.7), and incubated on ice for 4 min. Cells were lysed
mechanically by homogenization for 30 s. Following
lysis, 2 M sucrose was added to a ¢nal concentration
of 250 mM, and PMSF was added to a ¢nal concen-
tration of 1 mM. The lysate was centrifuged for 3 min
at 1200Ug, and the pellet was discarded. The super-
natant was then centrifuged at 14 000Ug for 10 min
and the supernatant discarded. The mitochondrial
pellet was then resuspended in 2.5 ml RSB+250
mM sucrose and 1 mM PMSF and centrifuged again
at 1200Ug to remove residual debris. Mitochondria
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were pelleted again for 10 min at 14 000Ug and were
resuspended in 200 Wl RSB+250 mM sucrose and
1 mM PMSF. The mitochondrial fractions were
separated using a 12% SDS-polyacrylamide gel and
electrotransferred to PVDF membrane, followed by
hybridization with an anti-VDAC1 speci¢c antibody
(Calbiochem) and detection with an anti-mouse IgG
antibody horseradish peroxidase conjugate (Sigma).
The chemiluminescent signal was developed using
0.068 mM p-coumuric acid, 1.25 mM luminol, and
0.0003% hydrogen peroxide (Sigma). Antiserum
against rat TOM-20 was generously provided by
Dr. Katsuyoshi Mihara (Kyushu University, Fukuo-
ka, Japan), and the antibody detected using an anti-
rabbit IgG antibody horseradish peroxidase conju-
gate (Sigma), followed by the same detection system.
Fig. 1. VDAC gene targeting. The genomic structure of each VDAC locus is represented at the top of each panel. (A) The VDAC1
targeting vector contains two arms of homology to the VDAC1 gene and a neomycin cassette replaces VDAC1 exons 2^5, including
the start codon. TK indicates the HSV-tk gene cassette used for negative selection. For VDAC1, targeting events in G418/FIAU re-
sistant ES cell colonies were identi¢ed by Southern blot analysis using the 0.8 kb EcoRI/SacI fragment located 5P of the gene as a
probe (black box). (B) For VDAC2 gene targeting the ¢rst two exons of VDAC2, including the start codon, and the VDAC2 pro-
moter region are replaced by a neomycin cassette. A 2.1 kb SpeI/EcoRI probe (black box) was used to screen for homologous recom-
bination events. (C) For the VDAC3 gene a neomycin cassette replaces the last four exons of VDAC3. Targeting events were identi-
¢ed using the 0.7 kb NotI/SpeI fragment located 5P of the gene as a probe (black box). The expected lengths, as well as a Southern
blot of the wild-type and targeted restriction fragments, are shown at the bottom of each panel.
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2.7. Statistical analysis
The data are expressed as the mean þ S.E.M. Stat-
view statistical software (Abacus Concepts) was used
to perform all analyses and plot the data graphically.
Statistical signi¢cance was taken as a P value of
90.05.
3. Results
3.1. Production of homozygous VDAC null ES cell
clones
Using AB2.2 ES cells as the DNA recipient, ho-
mologous recombination by the VDAC1 plasmid
was observed at a frequency of V20% (Fig. 1A).
The replacement of the VDAC1 gene with the neo-
mycin resistance gene was predicted to delete four of
the nine VDAC1 exons, including the exon that con-
tains the translation initiation codon, and would be
anticipated to lead to a null allele. These cells were
subsequently used as recipients of a second targeting
plasmid.
Following electroporation with the ¢rst VDAC2
targeting plasmid a single VDAC2 heterozygous ES
cell clone was identi¢ed among approximately 1000
ES cell colonies screened by Southern blotting. To
determine if the lack of homologous recombination
with the VDAC2 constructs was due to use of a non-
isogenic genomic library, a 129SvEv genomic V DNA
library was screened and a new set of VDAC2 ge-
nomic DNA clones isolated. A new targeting plasmid
was constructed and electroporated into ES cells
(Fig. 1B), and approximately 500 colonies were
screened by Southern blotting. The isogenic
VDAC2 construct led to a homologous recombina-
tion frequency of V25% (124/500). DNA sequencing
of the plasmids constructed from the two libraries
revealed a single DNA substitution approximately
every 300 nucleotides, suggesting that subtle strain
speci¢c sequence variations have a major impact on
the frequency of homologous recombination.
Initially, AB2.1 ES cells were electroporated with
the VDAC3 targeting plasmid, and a homologous
recombination frequency of V5% was found. Be-
cause of concerns about the chromosomal stability
of the AB2.1 cell line the same VDAC3 plasmid
was electroporated into AB2.2 ES cells, a total of
300 colonies were screened, and a homologous re-
combination frequency of V20% (61/300) was ob-
tained (Fig. 1C).
VDAC2 and VDAC3 homozygous null ES cells
were produced using a high G418 selection strategy
[19]. Southern blot analysis indicated that in ¢ve of
46 and two of 90 colonies picked from high G418
surviving VDAC2 and VDAC3 ES cell colonies, re-
spectively, loss of the wild-type allele had occurred
(Fig. 2). VDAC1 de¢cient ES cells could not be gen-
erated by this method due to a high frequency of
trisomy of mouse chromosome 11 in the targeted
cells (data not shown). To generate VDAC1 null cells
the neomycin cassette present in the original VDAC1
targeting vector was replaced with a puromycin re-
sistance cassette. VDAC1 heterozygous AB2.2 ES
cell lines (that were not trisomic) were electroporated
with this VDAC1 targeting construct. A total of 350
colonies were screened for targeted homologous re-
combination events, and seven colonies were double
targeted VDAC1 homozygous null ES cell lines (Fig.
2). A similar strategy was followed for generating
additional homozygous de¢cient VDAC2 cell lines
(Fig. 2). Loss of VDAC mRNA expression was con-
¢rmed by Northern blot analysis using the 3P un-
translated region of each cDNA as a probe (Fig. 3).
To determine whether loss of VDACs a¡ects the in
vitro growth of ES cells, the growth rate of each cell
line was measured by serially counting cultured cells
Fig. 2. VDAC1, VDAC2, and VDAC3 homozygous null ES
cells. A Southern blot of the mutant cell lines carried out with
the probes described in Fig. 1 is shown. The wild-type allele in
the heterozygous cells used to generate the homozygous cells is
indicated by the arrow. Loss of the wild-type allele is demon-
strated for each gene. Because the puromycin resistance cassette
is of a di¡erent size than the neomycin resistance cassette, use
of the puromycin marker gives rise to a second mutant band
(VDAC1 and VDAC2), whereas using high G418 selection
leads to duplication of the mutant band (VDAC3 panel on the
right).
BBAMCR 14545 4-10-99
S. Wu et al. / Biochimica et Biophysica Acta 1452 (1999) 68^7872
over a 5 day period. No statistically signi¢cant di¡er-
ence in growth rate was observed (data not shown),
indicating that although there is a demonstrable dif-
ference in cellular respiration (see below) this does
not translate into diminished growth characteristics,
at least in the context of cultured cells grown under
standard conditions (95% air, 5% CO2 [16]).
3.2. Sequential targeting of VDAC isoforms in
ES cells
To examine if the expression of more than one
VDAC isoform can be extinguished in ES cells, addi-
tional VDAC loci were sequentially targeted in ho-
mozygous ES cell clones. To conserve the available
selectable markers a puromycin cassette £anked by
loxP sites was constructed. The VDAC1 and VDAC2
null ES cell lines generated using a second targeting
construct with the puromycin-loxP cassette were
transiently transfected with a Cre expression plasmid,
plated at a low density, and screened for the excision
of the puromycin selectable marker. For both
VDAC1 and VDAC2 ES cell lines approximately
20% of the colonies demonstrated Cre mediated ex-
cision of the puromycin cassette by Southern blotting
(data not shown). The VDAC1 and VDAC2 null ES
cells were subsequently electroporated with VDAC2
and VDAC3 puromycin selectable targeting vectors
to inactivate an additional VDAC allele. A total of
three electroporations for each set were performed
and approximately 300 colonies were screened for a
homologous recombination event. No correctly tar-
geted ES cells were identi¢ed for either set, despite
using vectors that had previously targeted with 20^
C
Fig. 3. Homozygous VDAC de¢cient cells lack VDAC RNA.
Northern analysis of each VDAC de¢cient cell line. (A) Left to
right: wild-type ES cells, VDAC1 heterozygous ES cells, and
¢ve VDAC1 de¢cient cell lines. (B) Wild-type cells, ¢broblast
feeder cells (Sto cells), and ¢ve VDAC2 de¢cient cell lines. (C)
Similar control cells and two VDAC3 de¢cient cell lines. Each
¢lter was probed with the GAPDH cDNA to demonstrate com-
parable RNA loading and intactness. For VDAC2 de¢cient
cells, more RNA was examined to try to identify low level re-
sidual mRNAs. Use of multiple polyadenylation sites at the
VDAC2 locus accounts for the presence of three bands in the
control lanes [7]. 3P probes from each VDAC cDNA were used
to avoid cross-hybridization [7].
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25% e⁄ciency, suggesting that a minimum of two
biallelic VDACs are required in ES cells for viability.
3.3. Diminished respiration in VDAC de¢cient cells
YVDAC1 de¢cient yeasts have a respiratory defect
[4]. To determine whether de¢ciency of mammalian
VDACs leads to altered respiration, each cell line
was studied by polarography using intact cells. Basic
oxygen consumption was reduced by approximately
30% in each (Fig. 4A). Treatment of cells with oli-
gomycin, an inhibitor of complex V (ATP synthase),
led to similar results (Fig. 4B). Incubation with the
uncoupling agent CCCP led to a comparable increase
in total oxygen consumption that was signi¢cantly
di¡erent from wild-type cells for VDAC1 and
VDAC2 de¢cient cells (Fig. 4C). The fact that un-
coupled respiration in the VDAC3 de¢cient cells was
not statistically di¡erent from control cells (although
the trend was towards reduced respiration) suggests
the respiratory defect in these cells may di¡er from
that of VDAC1 and VDAC2. This result is reminis-
cent of our previous observation that mouse VDAC3
only partially complements YVDAC1 de¢cient yeast
when grown at the restrictive temperature [7,26], con-
sistent with a functional di¡erence between the
VDAC isoforms. Calculating the respiratory control
ratios (uncoupled respiration divided by oligomycin
sensitive respiration) shows values of 3, 2.9, 2.3, and
3 for control, VDAC1 de¢cient, VDAC2 de¢cient,
and VDAC3 de¢cient cells, respectively, indicating
that although oxygen consumption is reduced in
the absence of VDAC mitochondrial e⁄ciency (cou-
pling) remains largely unchanged. In contrast, the
increase in respiration in the presence of an uncou-
pler is similar for control, VDAC1 and VDAC3 de-
¢cient cells (V100%), whereas VDAC2 de¢cient cells
increase oxygen consumption less in the presence of
an uncoupler (V65%), suggesting a defect in the
respiratory chain in these cells.
To examine whether mitochondrial proliferation
occurs in response to the respiratory defect we deter-
mined the content of citrate synthase, a frequently
used matrix marker of cellular mitochondrial content
that is often increased in a variety of mitochondrial
disorders of humans [27]. Cells lacking VDAC1 have
a signi¢cant increase (V40%, P = 0.01) in activity
(Fig. 5A), possibly re£ecting an adaptive prolifera-
tion of mitochondria. Surprisingly, despite a similar
respiratory defect in VDAC2 and VDAC3 de¢cient
cells, citrate synthase activity was unchanged in these
cells, suggesting that there are di¡erent metabolic
signals that mediate the adaptive response or that
some other compensatory events occur.
Fig. 4. Respiration is reduced in VDAC de¢cient ES cells.
Graph A shows the basal respiration of intact wild-type ES
cells and each VDAC de¢cient cell line. Graph B shows the
oxygen consumption that is sensitive to inhibition with 10 WM
oligomycin (basic minus oligomycin insensitive oxygen con-
sumption). Graph C shows total respiration following uncou-
pling with 20 WM CCCP. The asterisk indicates that for
VDAC3 the result was not statistically di¡erent from the con-
trol value (mean þ S.E.M., P values and number of experimen-
tal determinations [n] as indicated).
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Based upon prior studies in YVDAC1 de¢cient
yeast [4] we determined cytochrome c oxidase
(COX) activity in each cell line (Fig. 5B). Although
absolute COX activity is signi¢cantly reduced only in
VDAC2 de¢cient cells, when COX activity is ex-
pressed as a function of citrate synthase activity to
re£ect mitochondrial content a signi¢cant reduction
in COX activity was observed in both VDAC1 and
VDAC2 de¢cient cells relative to control cells (ratio
0.726 þ 0.041, 0.483 þ 0.019, 0.498 þ 0.05 for wild-
type, VDAC1 and VDAC2 de¢cient cells, respec-
tively, P6 0.05), while COX activity in VDAC3 de-
¢cient cells was unchanged.
If there is a respiratory defect and enhanced gly-
colysis an increased level of lactate may be expected,
but while a trend towards higher lactate concentra-
tions was seen it was not statistically signi¢cant
(2.9 þ 0.23, 3.5 þ 0.46, 4.7 þ 0.98, and 3.5 þ 0.25
nmol/106 cells for control, VDAC1, VDAC2,
VDAC3 de¢cient cells, respectively). Likewise, hexo-
kinase, the rate limiting enzyme of glycolysis, can be
increased in association with increased glycolytic ac-
tivity, as has been observed in various solid tumors
[28]. However, each VDAC de¢cient cell line exhib-
ited a 15^60% decrease in total HK activity, with
VDAC3 showing the largest reduction in activity
(70.6 þ 3.1, 61.2 þ 1.8, 60.2 þ 4.9, and 44 þ 2.5 Wmol/
min/mg protein for control, VDAC1, VDAC2,
VDAC3 de¢cient cells, respectively, n = 6, P6 0.05).
3.4. Increased levels of VDAC1 in VDAC2 and
VDAC3 de¢cient cells
To determine if compensatory changes in VDAC1
expression occur in the absence of VDAC2 or
VDAC3 that could account for a failure to detect
Fig. 6. Western blot analysis of VDAC de¢cient cells. A
VDAC1-speci¢c antibody was used to determine the approxi-
mate content of VDAC1 in mitochondrial fractions from cells
lacking either VDAC2 or VDAC3. Lane 1: wild-type cells ; lane
2: VDAC1 heterozygous cells ; lane 3: VDAC1 de¢cient cells ;
lane 4: VDAC2 de¢cient cells ; lane 5: VDAC3 de¢cient cells.
The band intensity was determined by densitometry and mito-
chondrial protein content on the membrane normalized using
an antibody directed against a second mitochondrial outer
membrane protein, TOM-20. Three separate Western blots were
performed and a representative result is shown. The graph rep-
resents the results of the three experiments. Mean relative to
control cells þ S.E.M. (P = 0.05).
Fig. 5. Biochemical parameters of VDAC de¢cient cells. (A)
Citrate synthase and (B) cytochrome c oxidase activity (Wmol
cytochrome c oxidized/min/mg) in VDAC de¢cient ES cells.
Pair-wise comparison between wild-type cells and each VDAC
de¢cient cell was carried out, with the resulting P values indi-
cated (CS; n = 3 for each cell line, COX; n = 9 for each cell
line, mean þ S.E.M. shown).
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increased citrate synthase activity in VDAC2 and
VDAC3 de¢cient cells Western blotting was carried
out on isolated mitochondria. Using a commercial
monoclonal antibody raised against human VDAC1
that cross-reacts with the mouse VDAC1 protein,
Fig. 6 shows that, when normalized to the expression
of the mitochondrial outer membrane protein TOM-
20, the amount of VDAC1 protein increases when
VDAC2 or VDAC3 is absent. This result suggests
that in the absence of VDAC2 or VDAC3 there is
a compensatory increase in VDAC1 expression by
some as yet unde¢ned mechanism, perhaps account-
ing for the lack of mitochondrial proliferation in
these cells.
4. Discussion
In addition to the value of ES cells in generating
mutant mice, ES cells have been advocated as a mod-
el of early murine embryogenesis [29] and thus may
be a valuable tool for examining the metabolic
changes that occur during early development. ES
cells potentially provide an excellent model system
for studying mitochondrial function since they are
rich in mitochondria and can be caused to di¡eren-
tiate into distinct cell lineages by using varying cul-
ture conditions. Here we show that undi¡erentiated
ES cells express each VDAC isoform and thus can be
used to study the functions of each isoform, and
potentially VDAC function during early embryogen-
esis.
By gene targeting we demonstrate that each
VDAC isoform individually is dispensable, however
we were unable to generate cell lines lacking more
than one VDAC. These results suggest that mamma-
lian VDACs can complement each other and thus
must have some functional redundancy. To identify
biochemical consequences of VDAC de¢ciency we
examined in more detail energy production in these
cells by measuring the rate of respiration. Dihanich
et al. previously showed that de¢ciency of YVDAC1
leads to a respiratory defect with a dramatic reduc-
tion in COX activity [4], and our results, although
not of the magnitude reported in the yeast strain,
reveal a similar phenotype for VDAC2 and arguably
VDAC1. This di¡erence in degree may re£ect partial
functional overlap with the remaining isoforms. A
mechanistic explanation of this interaction between
VDAC and respiration remains to be determined but
some speculations are apparent. VDAC participates
in a multi-protein complex at the contact points be-
tween the mitochondrial inner and outer membrane,
including the adenine nucleotide translocator and, in
skeletal muscle, an intermembrane creatine kinase
[9,10]. Recent evidence suggests this complex, in con-
junction with cyclophilin, may constitute the perme-
ability transition pore [30,31], although there is con-
£icting evidence on this issue [32]. It has been
hypothesized that ADP may be channeled into the
matrix space via this complex, in particular when
hexokinase is bound [12]. The relatively diminished
respiration in VDAC de¢cient cells following uncou-
pling with CCCP suggests that ADP translocation is
not the limiting factor in these cells. Alternatively,
diminished translocation of other metabolites and
substrates leading to either reduced oxidation and/
or an altered redox potential may in£uence the elec-
tron transport pathway. The absence of VDAC may
also a¡ect the assembly or stability of the COX hol-
oenzyme and/or another respiratory chain complex,
although the mechanism for this is not obvious. Be-
cause the respiratory control ratio is very similar for
all of the ES cells, mitochondrial e⁄ciency appears
minimally a¡ected by loss of VDAC. This would be
consistent with a reduction in substrate availability,
suggesting that outer membrane permeability is per-
turbed, a ¢nding in concert with recent observations
in YVDAC1 de¢cient yeast [5].
Defective mitochondria can lead to increased num-
bers of mitochondria in a variety of human mito-
chondrial disorders [27], which is believed to be an
adaptive response, the biological signals for which
remain obscure. Only VDAC1 de¢cient cells exhibit
increased citrate synthase activity, despite the fairly
uniform abnormality in respiration in each mutant
cell line. This suggests that either VDAC1 de¢ciency
has some other as yet unrecognized mitochondrial
dysfunction leading to proliferation, or that speci¢c
signals exist for this phenomenon which occur only
in the absence of VDAC1. The observation that
VDAC1 is increased in VDAC2 and VDAC3 de¢-
cient cells indicates that regulatory signals exist to
coordinate this altered expression, with increased
VDAC1 expression perhaps obviating the need for
mitochondrial proliferation although not ameliorat-
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ing the respiratory de¢ciency. Determining whether a
similar up-regulation in the expression of VDAC2
and VDAC3 occurs in the absence of VDAC1 must
await the development of isoform speci¢c antibodies.
Based upon our observations in ES cells, VDACs
appear to couple outer membrane transport to inner
membrane respiration, and the reduced COX activity
observed in VDAC1 and VDAC2 de¢cient cells may
in part explain the apparent respiratory defect. COX
is a complex of 13 proteins, 10 of which are encoded
by nuclear genes and the remainder mitochondrially
encoded. Partial COX de¢ciency is found in over one
third of individuals in whom a respiratory chain de-
fect is identi¢ed [33]. To date no nuclear COX sub-
unit gene has been found to be defective in those
individuals with COX de¢ciency [34] and only two
examples of a mitochondrial mutation leading to
COX de¢ciency have been described [35^37]. Re-
duced COX activity associated with loss of VDAC1
and VDAC2 indicates that potentially a variety of
proteins that do not make up the COX complex
per se may lead to its de¢ciency. In yeast there are
over 30 genes that signi¢cantly a¡ect COX activity
yet are not components of the COX holoenzyme [38].
Interestingly, a human gene homologous to one of
these yeast genes has been shown to cause a severe
COX de¢ciency [39].
Finally, the ability to generate VDAC de¢cient ES
cells suggests VDAC de¢cient mice may be viable.
Additionally, the cell lines described here will be of
value in examining the role of VDACs in cytochrome
c mediated apoptosis and mitochondrial kinase bind-
ing.
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